CN105842469B - 绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 - Google Patents
绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 Download PDFInfo
- Publication number
- CN105842469B CN105842469B CN201610322808.0A CN201610322808A CN105842469B CN 105842469 B CN105842469 B CN 105842469B CN 201610322808 A CN201610322808 A CN 201610322808A CN 105842469 B CN105842469 B CN 105842469B
- Authority
- CN
- China
- Prior art keywords
- groove
- subunit
- micro
- hcg
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940088597 hormone Drugs 0.000 title claims abstract description 26
- 239000005556 hormone Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 24
- 210000001136 chorion Anatomy 0.000 title claims abstract description 17
- 230000001456 gonadotroph Effects 0.000 title claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 75
- 238000002156 mixing Methods 0.000 claims abstract description 51
- 239000006249 magnetic particle Substances 0.000 claims abstract description 46
- 239000007788 liquid Substances 0.000 claims abstract description 45
- 238000001514 detection method Methods 0.000 claims abstract description 33
- 238000002347 injection Methods 0.000 claims abstract description 32
- 239000007924 injection Substances 0.000 claims abstract description 32
- 210000004369 blood Anatomy 0.000 claims abstract description 26
- 239000008280 blood Substances 0.000 claims abstract description 26
- 238000004140 cleaning Methods 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 210000000601 blood cell Anatomy 0.000 claims abstract description 16
- 210000002381 plasma Anatomy 0.000 claims abstract description 16
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims abstract description 15
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims abstract description 15
- 239000003513 alkali Substances 0.000 claims abstract description 15
- 239000002699 waste material Substances 0.000 claims abstract description 14
- 230000001133 acceleration Effects 0.000 claims description 25
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims description 11
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims description 11
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims description 10
- 230000005540 biological transmission Effects 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 238000012360 testing method Methods 0.000 claims description 7
- 102000015872 Human beta Subunit Chorionic Gonadotropin Human genes 0.000 claims description 5
- 108010010590 Human beta Subunit Chorionic Gonadotropin Proteins 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical group [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 210000004907 gland Anatomy 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 238000009434 installation Methods 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229960004407 chorionic gonadotrophin Drugs 0.000 claims 2
- 210000004180 plasmocyte Anatomy 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 239000012295 chemical reaction liquid Substances 0.000 abstract description 4
- 230000035935 pregnancy Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 239000007853 buffer solution Substances 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000000762 glandular Effects 0.000 description 5
- 239000004005 microsphere Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- -1 Ethyl sulfonic acid monohydrate Chemical class 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 210000004246 corpus luteum Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- YMXHPSHLTSZXKH-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoate Chemical compound S1CC2NC(=O)NC2C1CCCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000007987 MES buffer Substances 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000016610 ataxia-hypogonadism-choroidal dystrophy syndrome Diseases 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 238000009938 salting Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 2
- RPENMORRBUTCPR-UHFFFAOYSA-M sodium;1-hydroxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].ON1C(=O)CC(S([O-])(=O)=O)C1=O RPENMORRBUTCPR-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- CCMKPCBRNXKTKV-UHFFFAOYSA-N 1-hydroxy-5-sulfanylidenepyrrolidin-2-one Chemical class ON1C(=O)CCC1=S CCMKPCBRNXKTKV-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 201000010374 Down Syndrome Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 description 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010048233 Procalcitonin Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- YPWFISCTZQNZAU-UHFFFAOYSA-N Thiane Chemical class C1CCSCC1 YPWFISCTZQNZAU-UHFFFAOYSA-N 0.000 description 1
- 102000003911 Thyrotropin Receptors Human genes 0.000 description 1
- 108090000253 Thyrotropin Receptors Proteins 0.000 description 1
- XYIPYISRNJUPBA-UHFFFAOYSA-N [3-(3'-methoxyspiro[adamantane-2,4'-dioxetane]-3'-yl)phenyl] dihydrogen phosphate Chemical compound O1OC2(C3CC4CC(C3)CC2C4)C1(OC)C1=CC=CC(OP(O)(O)=O)=C1 XYIPYISRNJUPBA-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012412 chemical coupling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940015047 chorionic gonadotropin Drugs 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 230000001808 coupling effect Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 208000018554 digestive system carcinoma Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000026109 gonad development Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 229940094892 gonadotropins Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 239000003726 plant lectin Substances 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001646 thyrotropic effect Effects 0.000 description 1
- 210000002993 trophoblast Anatomy 0.000 description 1
- 208000029387 trophoblastic neoplasm Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
- G01N35/00069—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides whereby the sample substrate is of the bio-disk type, i.e. having the format of an optical disk
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00029—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor provided with flat sample substrates, e.g. slides
- G01N2035/00099—Characterised by type of test elements
- G01N2035/00158—Elements containing microarrays, i.e. "biochip"
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Clinical Laboratory Science (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610322808.0A CN105842469B (zh) | 2016-05-13 | 2016-05-13 | 绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610322808.0A CN105842469B (zh) | 2016-05-13 | 2016-05-13 | 绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105842469A CN105842469A (zh) | 2016-08-10 |
CN105842469B true CN105842469B (zh) | 2018-04-17 |
Family
ID=56593426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610322808.0A Active CN105842469B (zh) | 2016-05-13 | 2016-05-13 | 绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105842469B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107478837B (zh) * | 2017-09-01 | 2018-12-14 | 北京华科泰生物技术有限公司 | 基于磁微粒的微流控化学发光检测系统及其应用 |
CN107655879B (zh) * | 2017-09-01 | 2018-12-18 | 北京华科泰生物技术有限公司 | 用于检测性腺系列的磁微粒的微流控化学发光检测系统 |
CN107643285B (zh) * | 2017-09-01 | 2018-12-18 | 北京华科泰生物技术有限公司 | 一种基于磁微粒的微流控化学发光检测系统及其应用 |
CN109999931B (zh) * | 2019-04-18 | 2023-08-11 | 天津诺迈科技有限公司 | 化学发光检测用微流控芯片及使用方法、试剂清洗方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223357A (zh) * | 2012-01-26 | 2013-07-31 | 三星电子株式会社 | 微流体设备及其控制方法 |
CN104597266A (zh) * | 2013-10-31 | 2015-05-06 | 逢甲大学 | 离心式检测平台及其运作流程 |
CN205910202U (zh) * | 2016-05-13 | 2017-01-25 | 绍兴普施康生物科技有限公司 | 绒毛膜促性腺激素β亚单位微流控盘片 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1939629A3 (en) * | 2006-08-11 | 2011-03-09 | Samsung Electronics Co., Ltd. | Centrifugal Force Based Magnet Position Control Device and Disk-Shaped Micro Fluidic System |
KR100960066B1 (ko) * | 2008-05-14 | 2010-05-31 | 삼성전자주식회사 | 동결건조시약이 저장된 미세유동장치 및 이를 이용한시료분석방법 |
-
2016
- 2016-05-13 CN CN201610322808.0A patent/CN105842469B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103223357A (zh) * | 2012-01-26 | 2013-07-31 | 三星电子株式会社 | 微流体设备及其控制方法 |
CN104597266A (zh) * | 2013-10-31 | 2015-05-06 | 逢甲大学 | 离心式检测平台及其运作流程 |
CN205910202U (zh) * | 2016-05-13 | 2017-01-25 | 绍兴普施康生物科技有限公司 | 绒毛膜促性腺激素β亚单位微流控盘片 |
Also Published As
Publication number | Publication date |
---|---|
CN105842469A (zh) | 2016-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105842469B (zh) | 绒毛膜促性腺激素β亚单位微流控盘片及其使用方法 | |
WO2016127301A1 (zh) | rT3化学发光免疫检测试剂盒及其检测方法和应用 | |
Rodgers et al. | Secretion of progesterone and prostaglandins by cells of bovine corpora lutea from three stages of the luteal phase | |
CN102662061A (zh) | 胶乳增强免疫比浊法测定人甲胎蛋白含量的试剂盒 | |
CN104628843B (zh) | 一种促甲状腺激素受体蛋白质、基因序列及其试剂盒 | |
CN103940816A (zh) | 一种测定人体中甘胆酸含量的试剂盒及制备方法 | |
JPH06258325A (ja) | 異なる2又は3種類のモノクローナル抗体を使用する 抗原測定法及び該モノクローナル抗体を利用した試験 キット | |
CN101566626A (zh) | 一种抗原检测方法及其应用 | |
CN104730257A (zh) | rT3化学发光免疫检测试剂盒及其检测方法和应用 | |
JP2004504129A (ja) | 磁性ナノ粒子の制御された凝集による増大した分離効率 | |
CN105785054A (zh) | 降钙素原定量检测的化学发光微流控盘片及其使用方法 | |
US7553676B2 (en) | Specific coupling reaction measuring method | |
CN105195243A (zh) | 一种肌红蛋白定量检测的磁微粒化学发光微流控芯片 | |
CN110702589A (zh) | 一种流式细胞仪检测外泌体的方法 | |
CN105891463A (zh) | 一种基于纳米磁微粒时间分辨荧光的β-HCG定量检测试剂盒 | |
CN107655879B (zh) | 用于检测性腺系列的磁微粒的微流控化学发光检测系统 | |
US11255858B2 (en) | Method for isolating cancer stem cells | |
GB2152664A (en) | Magnetic assay reagents | |
CN205650215U (zh) | 一种c反应蛋白定量检测的磁微粒化学发光微流控芯片 | |
CN205910202U (zh) | 绒毛膜促性腺激素β亚单位微流控盘片 | |
CN205910200U (zh) | 降钙素原定量检测的化学发光微流控盘片 | |
CN109061203A (zh) | 一种人绒毛膜促性腺激素检测试剂盒及其制备方法与使用方法 | |
CN206540921U (zh) | 一种具有磁力搅拌的先兆子痫检测试剂盒 | |
CN108303554A (zh) | 一种抗苗勒氏管激素的磁微粒化学发光免疫分析试剂盒 | |
JP2012150104A (ja) | 免疫学的測定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 408, building C, scientific research building, No. 398, mahuan Road, Lihai Town, Binhai New City, Shaoxing City, Zhejiang Province Patentee after: Zhejiang pushkang Biotechnology Co.,Ltd. Address before: 312366 Zhejiang city in Shaoxing Province, the coastal city of Shaoxing Ma Huanlu No. 398 Branch Center Patentee before: SHAOXING PUSHIKANG BIOTECHNOLOGY CO.,LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chorionic gonadotropin beta subunit microfluidic control disc and its usage method Granted publication date: 20180417 Pledgee: Zhejiang business bank Limited by Share Ltd. Shaoxing Shangyu branch Pledgor: Zhejiang pushkang Biotechnology Co.,Ltd. Registration number: Y2024980029809 |